Invitae Corp. (NVTA)

21.64
NYSE : Health Services
Prev Close 21.14
Day Low/High 20.98 / 21.77
52 Wk Low/High 9.04 / 28.75
Avg Volume 2.34M
Exchange NYSE
Shares Outstanding 95.17M
Market Cap 2.01B
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
Invitae Announces Third Quarter 2015 Financial Results And Raises 2015 Volume Guidance

Invitae Announces Third Quarter 2015 Financial Results And Raises 2015 Volume Guidance

Invitae Corporation (NYSE: NVTA) today reported financial and operating results for the third quarter ended September 30, 2015.

Christine Gorjanc Joins Invitae's Board Of Directors (Photo: Business Wire)

Christine Gorjanc Joins Invitae's Board Of Directors (Photo: Business Wire)

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced the appointment of Christine M.

Invitae To Provide Testing For Sudden Death In The Young (SDY) Case Registry To Advance Understanding Of Sudden Death In The Young

Invitae To Provide Testing For Sudden Death In The Young (SDY) Case Registry To Advance Understanding Of Sudden Death In The Young

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it has entered into a collaboration with the Sudden Death in the Young (SDY) Case Registry, the first ever active surveillance...

Invitae To Announce Third Quarter 2015 Financial Results And Host Conference Call On November 5, 2015

Invitae To Announce Third Quarter 2015 Financial Results And Host Conference Call On November 5, 2015

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it will report its third quarter 2015 financial results on Thursday, November 5, 2015, and will host a conference call that day...

Invitae Expands Its Cardiology Offering To Provide More Comprehensive Testing For Patients And Their Families

Invitae Expands Its Cardiology Offering To Provide More Comprehensive Testing For Patients And Their Families

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced the expansion of its cardiology offering, including more than 30 cardiovascular test panels for arrhythmias, cardiomyopathies,...

Invitae Expands Its Hereditary Cancer Offering

Invitae Expands Its Hereditary Cancer Offering

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it is releasing the next generation of comprehensive cancer panels, providing broader panels and new testing categories.

Invitae Expands Its Neuromuscular Offering With Broad, Affordable Panels And New Testing Categories For Patients

Invitae Expands Its Neuromuscular Offering With Broad, Affordable Panels And New Testing Categories For Patients

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced it now offers genetic testing for neuromuscular diseases, including Duchenne/Becker muscular dystrophy, dystonia, and pediatric...

Invitae Expands Its Offering For Rare Disease And Pediatric Conditions With Broader, Affordable Genetic Tests

Invitae Expands Its Offering For Rare Disease And Pediatric Conditions With Broader, Affordable Genetic Tests

nvitae Corporation (NYSE: NVTA), a genetic information company, today announced that it has started to expand its offering of genetic tests for rare diseases and pediatric conditions, providing broader panels and...

Invitae Expands Test Menu To Include Hundreds Of New Genes, Dozens Of New Test Panels For Cancer, Cardiology, Neuromuscular, Pediatrics, And Rare Disorders

Invitae Expands Test Menu To Include Hundreds Of New Genes, Dozens Of New Test Panels For Cancer, Cardiology, Neuromuscular, Pediatrics, And Rare Disorders

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it has more than doubled the size of its genetic testing platform to include more than 600 genes and will release the new content...

Invitae To Host Investor Conference Call On October 7, 2015 To Discuss Expanded Genetic Testing Menu

Invitae To Host Investor Conference Call On October 7, 2015 To Discuss Expanded Genetic Testing Menu

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it will host an investor conference call on Wednesday, October 7 at 4:30 p.

Relative Strength Alert For Invitae

Relative Strength Alert For Invitae

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Invitae Announces New Education Program To Accelerate The Use Of Family History And Increase Awareness Of Genetic Testing

Invitae Announces New Education Program To Accelerate The Use Of Family History And Increase Awareness Of Genetic Testing

A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers - a significant increase over just a few years ago.

Invitae To Present At The 2015 Morgan Stanley Global Healthcare Conference

Invitae To Present At The 2015 Morgan Stanley Global Healthcare Conference

Invitae Corporation (NYSE:NVTA) today announced that members of the company's management team will present at the 2015 Morgan Stanley Global Healthcare Conference on Friday, September 18, 2015 at approximately 8:45...

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks under $10 look ready to break out and trade higher from current levels.

Invitae And Collaborators Announce Publication Of New Data Showing The Clinical Actionability Of Multi-Gene Panel Testing For Hereditary Breast And Ovarian Cancer Risk In JAMA Oncology

Invitae And Collaborators Announce Publication Of New Data Showing The Clinical Actionability Of Multi-Gene Panel Testing For Hereditary Breast And Ovarian Cancer Risk In JAMA Oncology

Invitae Corporation (NYSE: NVTA), a genetic information company, and its collaborators announced the publication of new data describing the clinical actionability of multi-gene testing for hereditary breast and...

Invitae Enters Oversold Territory (NVTA)

Invitae Enters Oversold Territory (NVTA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Invitae Raises Volume Guidance, Announces Second Quarter 2015 Financial Results

Invitae Raises Volume Guidance, Announces Second Quarter 2015 Financial Results

Invitae Corporation (NYSE: NVTA) today reported financial and operating results for the second quarter ended June 30, 2015.

Invitae To Present At The Canaccord Genuity 35th Annual Growth Conference

Invitae To Present At The Canaccord Genuity 35th Annual Growth Conference

Invitae Corporation (NYSE:NVTA) today announced that members of the company's management team will present at the Canaccord Genuity 35th Annual Growth Conference on Thursday, August 13, 2015 at approximately 3:30 p.

Invitae To Announce Second Quarter 2015 Financial Results And Host Conference Call On August 6, 2015

Invitae To Announce Second Quarter 2015 Financial Results And Host Conference Call On August 6, 2015

Invitae Corporation ( NYSE: NVTA), a genetic information company, today announced that it will report its second quarter 2015 financial results on Thursday, August 6, 2015 and will host a conference call that day at...

Invitae Announces Online Publication Of Data Comparing Traditional And Multi-Gene Panel Testing For Hereditary Breast And Ovarian Cancer In The Journal Of Molecular Diagnostics

Invitae Announces Online Publication Of Data Comparing Traditional And Multi-Gene Panel Testing For Hereditary Breast And Ovarian Cancer In The Journal Of Molecular Diagnostics

Invitae Corporation (NYSE:NVTA), a genetic information company, and collaborators announced the publication of data directly comparing traditional and multi-gene panel testing in more than 1,000 patients in The...

NYSE Executive Expects Plethora of IPOs to Continue

NYSE Executive Expects Plethora of IPOs to Continue

Garvis Toler, head of global capital market for the exchange, said the JOBs Act has encouraged companies to go public, a trend he expects to continue.

Biotech, Health Care Likely to Drive IPOs at NYSE in Second Half

Biotech, Health Care Likely to Drive IPOs at NYSE in Second Half

Garvis Toler, head of global capital markets at the NYSE, reviews the landscape of IPOs during the first half of 2015 and previews what's in store for the second half.

Invitae Launches New Patient Pay Price Of $475 For Its Full Menu Of Genetic Tests

Invitae Launches New Patient Pay Price Of $475 For Its Full Menu Of Genetic Tests

Invitae Corporation (NYSE: NVTA), a genetic information company, announced today the launch of its new patient pay price for its full menu of genetic tests at $475 per indication.

Invitae And Collaborators To Present New Data At The 2015 American Society Of Clinical Oncology Annual Meeting Focusing On The Clinical Utility Of Multi-Gene Panel Tests For Hereditary Breast And Ovarian Cancer

Invitae And Collaborators To Present New Data At The 2015 American Society Of Clinical Oncology Annual Meeting Focusing On The Clinical Utility Of Multi-Gene Panel Tests For Hereditary Breast And Ovarian Cancer

Invitae Corporation (NYSE:NVTA), a genetic information company, announced that new data will be presented during the 51st American Society of Clinical Oncology (ASCO) Annual Meeting.

Invitae Announces First Quarter 2015 Financial Results And Highlights

Invitae Announces First Quarter 2015 Financial Results And Highlights

Invitae Corporation (NYSE: NVTA) today reported financial and operating results for the first quarter ended March 31, 2015.

Invitae To Announce First Quarter 2015 Financial Results And Host Conference Call May 12, 2015

Invitae To Announce First Quarter 2015 Financial Results And Host Conference Call May 12, 2015

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it will report its first quarter 2015 financial results on Tuesday, May 12, 2015.

Invitae Appoints Robert Nussbaum, M.D., As Chief Medical Officer

Invitae Appoints Robert Nussbaum, M.D., As Chief Medical Officer

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced the appointment of Robert L.

Invitae Presents New Data Demonstrating Use Of Next-Generation Sequencing For Multi-Gene Panels At The 2015 American College Of Medical Genetics Annual Clinical Genetics Meeting

Invitae Presents New Data Demonstrating Use Of Next-Generation Sequencing For Multi-Gene Panels At The 2015 American College Of Medical Genetics Annual Clinical Genetics Meeting

Invitae Corporation (NYSE:NVTA), a genetic information company, is presenting seven posters at the 2015 American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting, including data demonstrating the use of...

Invitae To Present Seven Posters Highlighting New Data On The Use Of Next-Generation Sequencing For Multi-Gene Panels At The 2015 American College Of Medical Genetics Annual Clinical Genetics Meeting

Invitae To Present Seven Posters Highlighting New Data On The Use Of Next-Generation Sequencing For Multi-Gene Panels At The 2015 American College Of Medical Genetics Annual Clinical Genetics Meeting

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced it will be presenting seven posters at the 2015 American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting in Salt Lake City.

Invitae Announces Fourth Quarter And 2014 Year-End Financial Results And Highlights And Provides 2015 Outlook

Invitae Announces Fourth Quarter And 2014 Year-End Financial Results And Highlights And Provides 2015 Outlook

Invitae Corporation (NYSE:NVTA) today reported financial and operating results for the fourth quarter and year ended December 31, 2014.

TheStreet Quant Rating: D (Sell)